Clinical Medicine Insights: Pathology 2015:8 17-21
Original Research
Published on 19 Apr 2015
DOI: 10.4137/CPath.S23035
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Pathology
Background: Pleomorphic adenoma (PA) is the most common tumor of the salivary gland, while basal cell adenoma (BCA) is an uncommon neoplasm. Blood and lymphatic vessels are crucial for tumor metabolism. The aim of this study was to compare the blood and lymphatic vascular density and vascular and endothelial growth factor (VEGF) expression in PA and BCA tumors. In addition, cell proliferation was evaluated in these tumors.
Methods: Blood and lymphatic vessel content, VEGF expression, and cell proliferation were analyzed in 30 cases of PA and 13 cases of BCA by immunohistochemistry using antibodies for CD34, CD105, D2–40, VEGF, and Mcm-2.
Results: Regarding CD34 and CD105 expression, PA demonstrated a high vascularity and a low number of positive vessels, respectively. D2–40-positive lymphatic vessels were mainly located in the tumor capsules, with small intratumoral lymphatic vessels observed occasionally. VEGF expression revealed a remarkably heterogeneous immunoreactivity, alternating from weak or negative to positive or intense. BCA presented significantly higher CD34, CD34, CD105, D2–40, and VEGF expression compared to PA. No significant difference was found in cell proliferation between the tumors.
Conclusion: Although PA and BCA are considered part of the same spectrum of differentiation, this study showed that the blood and lymphatic vascularization of these tumors is different.
PDF (1.94 MB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
PMC HTML
I experienced rapid and fair peer review and fast article publication. The competent editorial and production staff at Libertas Academica were attentive to every detail and were great at communicating with us during the review and publication process. Thank you for your great service.
Facebook Google+ Twitter
Pinterest Tumblr YouTube